RLFTF Cov19 opportunity and investment The drug
Post# of 148183
The drug appears to have great promise for patients with respiratory issues and we all know this is really needed. That said for folks that buy on share price alone that there are 2.1 billion shares issued yet they don't have the capital to complete the Covid trials. It is quite speculative to play this as a double digit share price stock. I have done some research and may jump in if the price falls before the trial results are announced. Note it is also traded on the Swiss stock exchange quite heavily.
Good luck with your investing